Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update
Shahid A. Khan(Imperial College London), Harpreet Wasan(Hammersmith Hospital), Andrew V. Thillainayagam(Imperial College London), Brian R Davidson(University College Hospital), Robert Goldin(Imperial College London), Nigel Heaton(King's College Hospital), Simon D. Taylor‐Robinson(St Mary's Hospital), Stephen P. Pereira(The Royal Free Hospital), William Rosenberg(University of Southampton), John Karani(King's College Hospital), Howard C. Thomas(St Mary's Hospital), Paul Tait(Imperial College London)
Cited by 792
Related Papers
Encorafenib, Binimetinib, and Cetuximab in <i>BRAF</i> V600E–Mutated Colorectal Cancer
|New England Journal of Medicine|2019|1.5k
Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study
|The Lancet Oncology|2019|1.2k
MUTATION PREVENTING FORMATION OF HEPATITIS B e ANTIGEN IN PATIENTS WITH CHRONIC HEPATITIS B INFECTION
|The Lancet|1989|1.2k
HLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus Infection
|Science|2004|1.2k
Serum markers detect the presence of liver fibrosis: A cohort study
|Gastroenterology|2004|1.1k